By Author
  By Title
  By Keywords

June 1995, Volume 45, Issue 6

Original Article

A New Breakthrough in Treatment of Visceral Leishmaniasis in Children

Mumtaz Hassan  ( The Children’s Hospital, Pakistan Institute of Medical Sciences, Islarnabad. )
Dhani Bux Baat  ( The Children’s Hospital, Pakistan Institute of Medical Sciences, Islarnabad. )
Khalid Hassan  ( Department of Haematology, Rawalpindi Medical College, Rawalpindi. )


Fifty cases of visceral leishmaniasis were admitted in Children’s Hospital, Islamabad. Common clinical features were fever (100%), splenomegaly (100%), hepatomegaly (100%), anaemia (96%), abdominal distension (40%), bronchopneumonia (26%) and bleeding diathesis (22%). Hb was below 7.0 G/dl in 80%, white cell count below 4x109/cmm in 88% and platelet count below 100x109/c4mm in 86%. All the patients showed leislunania donovani bodies in the marrow smears. Fourteen patients were treated with aminosid­me (15 mg/kg), intramuscularly daily for 4 weeks. All responded dramatically and none of them went into relapse in a year’s follow-up. No side-effects were observed. Aininosidine can therefore, be recommended as a treatment of choice for visceral leishmaniasis in children (JPMA 45:155, 1995).


Visceral leishmaniasis, also known as Kala-Azaroccurs in many sub-tropical and tropical areas, like Mediterranean, Central Asia, China, Middle East, India, Northern Pakistan, Africa and South as well as Central America. Leishmaniasis represents a major health hazard for children and should be specially emphasized since this age group is not only more vulnerable1 ,but is also the group in which the risk of failure of diagnosis is the highest. If left untreated, it has a high mortality rate2. In Pakistan, visceral leishrnaniasis was first reported from the northern areas in the late fifties and early sixties3. The disease was thought to be restricted to foci in Gilgit and Skurdu, but since early eighties, cases of visceral leishmani­asis in children have been reported not only from different areas of AzadKashmir, but also in some extreme north-eastern areas of Punjab as well as nearby localities of NWFP4,5.
Visceral leishnrnniasis in children is endemic in some areas of Azad Kashmir6 and afew areas of northern Punjab and NWFP. In addition, tourists visiting the endemic areas are also at risk and the disease may be taken to other areas of Pakistan. In fact two cases of visceral leishmaniasis have already been reported from Karachi; one of them never left the city5. In Multan there was an epidemic of cutaneous leishmaniasis in 1971-19727. As regards the vector of the disease, a sand fly-Phle­botomus?apatasii is responsible for spread of disease in Azad Kashmir8. In northern areas of the country, the sand fly identified is Phiebotomus burneyi9. dogs, foxes and jackals are important reservoirs of infection10.Visceral leishmaniasis in Pakistan, has no uniform and clearly defined treatment protocol. However, cases have been treated with pentavalent antirnomals with good results. The major problem is not only of availability of these drugs, but also the cost is much bigger a problem. Furthermore, prolonged hospitalization of these patients adds another burden on already poorly existing health facilities.
At Children’s Hospital, Islamabad, patients of visceral leishmaniasis were treated withPentostam (Sodium Stiboglu­conate) in recommended doses. This drug suddenly became unavailable in the market, therefore, we started looking for alternative and cheaper medication. Aminosidine (Gabromy­cin) has been used in Kenya with good results in adults11. This study reports the clinical pattern and the results of a new and cheaper treatment (aminosidine) of visceral leishmaniasis in children.

Patients and Methods

Between 1987 and 1991, fifty cases of visceral leishma­niasis were admitted in Children’s Hospital, Islamabad. In every case, detailed clinical notes were entered in a profonna, especially relating to age, sex, duration of illness, fever, pallor, abdominal distension, hepatomegaly, splenomegaly, bleeding diathesis, cough and nutritional status. A complete blood picture (including haemoglobin, total leucocyte count, platelet count and differential leucocyte count) was performed. In all the patients, bone marrow was aspirated, using Saleh’s bone marrow aspiration needle: the smears were stained by May-Grunwald-Giemsa stain. In 34 cases immuno-fluorescent test for Leishmania denovanii (IFT) was also perfonned. Thirty-six cases were treated with pentostam (Sodium Stibo- gluconate) and 14 with aminosidine (Gabromycin) 15 mg/kg, intramuscularly. The effect and clinical response to aminosidine, especially in relation to fever, regression of spleen, peripheral blood picture and finally on bone marrow biopsy was evaluated. Since aminosidine is an aminogly­coside, so side effects were monitored. All the patients were closely watched for renal functions and hearing problems.


Age and Sex Distribution
Of 50 cases of visceral leishmaniasis, 36 were male and 14 female with a male:female ratio of 2.3:1. Majority of patients (80%) were between 1 to 5 years of age; 10% were below one year and 10% more than 5 years. The mean age was 2.6 years. Majority of patients were from northern areas. Bagh, Rawalakot and Muzaffarabad had maximum number of cases. Three cases were from Muree, one each from GujarKhan and Karak (Table I).

Fever, splenomegaly and hepatomegaly were invariably present. Other common manifestations were anemia (96%), abdominal distension (40%), bronchopneumonia (26%), bleeding diathesis (22%) and lymphadenopathy (18%) as shown in Table II.

Since majority of the patients were from northern areas with prolonged fever and hepatosplenomegaly, it was pre­sumedthatthis clinical triad (Azad Kashrnir+ Prolonged fever + Hepatosplenomegaly) indicated visceral leishmamasis un­less proven otherwise. Leishmaniasis being chronic ailment was associated with loss of appetite and weight loss.

Table Ill shows the nutritional status of patients accord­ing to Gomez Classification. Laboratory investigations (Table IV)<

showed leu­copema and haemoglobin below 7.0 grams/dl in 80%, platelet count below 100x109/L in 86% and increase in erythrocyte sedimentation rate in 88% of cases. Ifl all the cases, Leishmaniadonovani bodies were diagnostically seen in bone marrow smears. Immunofluorescent test performed in 34 patients at National Institute of Health, Islamabad was positive in 85.2% of cases. Cases of visceral leishmaniasis were treated with Pentostam (Sodium Stibogluconate) in recommended doses, till it became unavailable. As a substitute Aminosidine (Gabromycin) used in Kenya with good results in adults was administered in 14 new cases, in a dosage of 15 mg/kg intramuscularly daily for four weeks and response was monitored regularly. Fever settled in 7-10 days and spleen started regressing to normal size by 3rd week. There were no relapses in a follow up for one year. Since Aminosidine is an Aminoglycoside, so side effects were monitored. Renal functions and hearing test revealed no damage.


Leishmaniasis is endemic in Northern Areas of Paki­stan3,4. There are few cases reported from Punjab and one from Karak (NWFP) in our study. Sodium Stibogluconate (Pento­stam) has remained the treatment of choice8. The results of treatment with Aminosidine alone and in combination with Pentostam reported by Change et al11 were encouraging though this was mainly in adults. It is an aminoglycoside which has been givenby 1/M injections i.e., 15 mg/kg perdose for 4 weeks. Results were very gratifying with fever settling down in 7 days and other symptoms improvedby 10th day. All the hematological changes reversed back to normal at the end of treatment. Enlarged spleen regressed to normal size by the end of 3rd week. There were no relapses in 1 year follow-up. Aminosidine has high affinity for ribosomal subunit 30 s, causing a mis-reading of messenger RNA, giving rise to production of anomalous proteins. This is potent antibacterial agent aganst both gram positive and gram negative organ­isms. Absence of serious side effects of nephrotoxicity or ototoxicity in our 14 patients were very encouraging.
The most important factor in our country is cost of treatment per course. A course of aminosidine was only Rs.400/-, as compared to Rs.2000/- in case of pentostam. Due to an excellent response in terms of clinical recovery and splemc regression, no side effects and easy affordability, we recommend aminosidine as treatment of choice for visceral leishmaniasis in children.


1. Kager, Piet, A. Visceral leishmaniasis. Med. Tnt., 198 8;3 :2235-39.
2. WHO, Control of the leishmaniasis. WHO Tech. Rep. Ser., 1990;793-800.
3. Ahmed, N., Burney, M. 1. and Wazir, Y. A. Preliminaiy report on the study of Kala-azar in Baltistan (West Pakistan) Pak. Armed Forces Med. J., 1960,10:1-10.
4. Ahmed, N. and Bumey, M. I. Leishmaniasis in Northern areas of Pakistan (Baltistan), Pak. Armed Forces Med. J., 1962;12:1-12.
5. Rehman, M., Rab, S. M. Kazmi, A. K. et al. Visceral leishmaniasis (Kala-azar) in Karachi. J. Pak. Med. Assoc., 1989;39:244-45.
6. Saleem, M., Anwar, C. M. and Malik, I. A. Visceral leishmaniasis in children. A new focus inAzadKashmir. 7. Pak. Med. Assoc., 1986;36:230-34.
7. Haq, G. Leishmaniasis. J. Pak. Med. Assoc., 1989,39:223-24.
8. Bumey, M. I., and Lari, F. A. A longitudinal study of visceral leishmaniasis in Northern areas of Pakistan. Trop. Doct., 1979;9:110-16.
9. Undani, P. M. Nelson Text book of paediatrics, Philadelphia, London, Toronto, W. B. Saunder Ltd., 1979, pp. 777.80.
10. Change, C.N., Owate, 7., Pamba, H. 0. et al. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Trans. R. Soc. Trop. Med. Hyg., 1990;84:221-25.

Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: